Johnson & Johnson (JNJ) stock
JNJNYSEPharmaceutical PreparationsFiscal year ends January 3
Financials through Q3 FY2026, quarter ended Sep 27, 2026Last filing: 10-Q on Oct 21, 2026Score 12/3086% above fair value
$272.70−6.00 (-2.15%)
Close on Nov 18, 2026Market cap $656.47BP/E 41.4Yield 1.88%
Johnson & Johnson operating cash flow
Operating cash flow is the cash the business generates from its day-to-day operations.
Johnson & Johnson's operating cash flow for the twelve months ending Sep 27, 2026 was $26.16B, up 8.1% year over year. For fiscal 2025 it was $24.53B, up 1.1% from the year before. Over ten years it grew 2.3% a year on average. The highest annual figure on record is $24.53B in fiscal 2025.
Annual operating cash flow
| Period | Period end | Value | Change |
|---|---|---|---|
| FY2025 | Dec 28, 2025 | $24.53B | +1.1% |
| FY2024 | Dec 29, 2024 | $24.27B | +6.5% |
| FY2023 | Dec 31, 2023 | $22.79B | +7.5% |
| FY2022 | Jan 1, 2023 | $21.19B | -9.5% |
| FY2021 | Jan 2, 2022 | $23.41B | -0.5% |
| FY2020 | Jan 3, 2021 | $23.54B | +0.5% |
| FY2019 | Dec 29, 2019 | $23.42B | +5.5% |
| FY2018 | Dec 30, 2018 | $22.20B | +5.4% |
| FY2017 | Dec 31, 2017 | $21.06B | +12.2% |
| FY2016 | Jan 1, 2017 | $18.77B | -4.1% |
| FY2015 | Jan 3, 2016 | $19.57B | +4.6% |
| FY2014 | Dec 28, 2014 | $18.71B | +7.4% |
| FY2013 | Dec 29, 2013 | $17.41B | +13.1% |
| FY2012 | Dec 30, 2012 | $15.40B | +7.7% |
| FY2011 | Jan 1, 2012 | $14.30B | -12.7% |
| FY2010 | Jan 2, 2011 | $16.39B | -1.1% |
| FY2009 | Jan 3, 2010 | $16.57B | +10.7% |
| FY2008 | Dec 28, 2008 | $14.97B | -0.3% |
| FY2007 | Dec 30, 2007 | $15.02B | – |
Quarterly operating cash flow
Change is against the same quarter a year earlier.
| Period | Period end | Value | Change |
|---|---|---|---|
| Q3 FY2026 | Sep 27, 2026 | $7.72B | -15.8% |
| Q2 FY2026 | Jun 28, 2026 | $8.62B | +122.2% |
| Q1 FY2026 | Mar 29, 2026 | $2.51B | -39.8% |
| Q4 FY2025 | Dec 28, 2025 | $7.31B | +4.7% |
| Q3 FY2025 | Sep 28, 2025 | $9.17B | +14.7% |
| Q2 FY2025 | Jun 29, 2025 | $3.88B | -31.2% |
| Q1 FY2025 | Mar 30, 2025 | $4.17B | +14.1% |
| Q4 FY2024 | Dec 29, 2024 | $6.98B | -11.2% |
| Q3 FY2024 | Sep 29, 2024 | $7.99B | +6.7% |
| Q2 FY2024 | Jun 30, 2024 | $5.63B | +34.7% |
| Q1 FY2024 | Mar 31, 2024 | $3.66B | +12.3% |
| Q4 FY2023 | Dec 31, 2023 | $7.86B | +47.0% |
| Q3 FY2023 | Oct 1, 2023 | $7.49B | +19.2% |
| Q2 FY2023 | Jul 2, 2023 | $4.18B | -25.1% |
| Q1 FY2023 | Apr 2, 2023 | $3.26B | -18.1% |
| Q4 FY2022 | Jan 1, 2023 | $5.35B | -6.7% |
| Q3 FY2022 | Oct 2, 2022 | $6.28B | -24.2% |
| Q2 FY2022 | Jul 3, 2022 | $5.58B | +5.0% |
| Q1 FY2022 | Apr 3, 2022 | $3.98B | -2.3% |
| Q4 FY2021 | Jan 2, 2022 | $5.73B | -31.3% |
| Q3 FY2021 | Oct 3, 2021 | $8.29B | -1.1% |
| Q2 FY2021 | Jul 4, 2021 | $5.31B | +53.9% |
| Q1 FY2021 | Apr 4, 2021 | $4.07B | +21.3% |
| Q4 FY2020 | Jan 3, 2021 | $8.34B | +30.4% |
| Q3 FY2020 | Sep 27, 2020 | $8.38B | +11.4% |
| Q2 FY2020 | Jun 28, 2020 | $3.45B | -42.0% |
| Q1 FY2020 | Mar 29, 2020 | $3.36B | -5.2% |
| Q4 FY2019 | Dec 29, 2019 | $6.40B | +2.5% |
| Q3 FY2019 | Sep 29, 2019 | $7.53B | +20.0% |
| Q2 FY2019 | Jun 30, 2019 | $5.95B | -2.2% |
| Q1 FY2019 | Mar 31, 2019 | $3.54B | -1.7% |
| Q4 FY2018 | Dec 30, 2018 | $6.24B | +2.3% |
| Q3 FY2018 | Sep 30, 2018 | $6.27B | +0.1% |
| Q2 FY2018 | Jul 1, 2018 | $6.08B | +5.3% |
| Q1 FY2018 | Apr 1, 2018 | $3.61B | +23.8% |
| Q4 FY2017 | Dec 31, 2017 | $6.11B | -8.2% |
| Q3 FY2017 | Oct 1, 2017 | $6.27B | – |
| Q2 FY2017 | Jul 2, 2017 | $5.77B | – |
| Q1 FY2017 | Apr 2, 2017 | $2.91B | – |
| Q4 FY2016 | Jan 1, 2017 | $6.65B | – |
See a number that looks wrong?